[Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?].

Objectives: The use of anthracyclines are limited by their cardiotoxic side effects (first of all congestive cardiomyopathy). In this study we analyzed the anthracycline-induced cardiotoxicity and the possible preventive role of dexrazoxane in children.

Patients: 158 anthracycline-treated long-term survivors could be analyzed.